COMPARISON OF THE INTERMEDIATE COMPLEXES OF HUMAN GROWTH-HORMONE BOUND TO THE HUMAN GROWTH-HORMONE AND PROLACTIN RECEPTORS

被引:74
|
作者
KOSSIAKOFF, AA [1 ]
SOMERS, W [1 ]
ULTSCH, M [1 ]
ANDOW, K [1 ]
MULLER, YA [1 ]
DEVOS, AM [1 ]
机构
[1] GENENTECH INC,DEPT PROT ENGN,S SAN FRANCISCO,CA 94080
关键词
CRYSTAL STRUCTURES; HUMAN GROWTH HORMONE; HUMAN PROLACTIN; MOLECULAR RECOGNITION PROCESSES; RECEPTORS;
D O I
10.1002/pro.5560031008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The crystal structures of complexes of human growth hormone (hGH) with the growth hormone and prolactin receptors (hGHR and hPRLR, respectively), together with the mutational data available for these systems, suggest that an extraordinary combination of conformational adaptability, together with finely tuned specificity, governs the molecular recognition processes operative in these systems. On the one hand, in the active 1:2 ligand-receptor complexes, 2 copies of the same receptor use the identical set of binding determinants to recognize topographically different surfaces on the hormone. On the other hand, comparing the 1:1 hGH-hGHR and hGH-hPRLR complexes, 2 distinct receptors use this same set of binding determinants to interact with the identical binding site on the ligand, even though few residues among the binding determinants are conserved. The structural evidence demonstrates that this versatility is accomplished by local conformational flexibility of the binding loops, allowing adaptation to different binding environments, together with rigid-body movements of the receptor domains, necessary for the creation of specific interactions with the same binding site.
引用
收藏
页码:1697 / 1705
页数:9
相关论文
共 50 条
  • [31] GROWTH-HORMONE AND GROWTH-HORMONE BINDING-PROTEIN IN HUMAN URINE
    HATTORI, N
    SHIMATSU, A
    KATO, Y
    IMURA, H
    KIDNEY INTERNATIONAL, 1990, 37 (03) : 951 - 954
  • [32] TRANSITORY GROWTH-HORMONE DEFICIENCY SUCCESSFULLY TREATED WITH HUMAN GROWTH-HORMONE
    TRYGSTAD, O
    ACTA ENDOCRINOLOGICA, 1977, 84 (01): : 11 - 22
  • [33] RESULTS OF INTERMITTENT TREATMENT OF GROWTH-HORMONE DEFICIENCY WITH HUMAN GROWTH-HORMONE
    PREECE, MA
    TANNER, JM
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1977, 45 (01): : 169 - 170
  • [34] GROWTH-HORMONE DEFICIENCY IN DOWN - TREATMENT WITH SYNTHETIC HUMAN GROWTH-HORMONE
    TORRADO, C
    WISNIEWSKI, K
    CASTELLS, S
    PEDIATRIC RESEARCH, 1990, 27 (04) : A87 - A87
  • [35] HUMAN, BOVINE, AND EQUINE GROWTH-HORMONE ANTIBODIES IN PATIENTS TREATED WITH HUMAN GROWTH-HORMONE
    POSKUS, E
    PENA, C
    PEREZ, AR
    VITA, N
    HEINRICH, JJ
    PALADINI, AC
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1982, 55 (01): : 13 - 17
  • [36] COMPARISON OF GROWTH-HORMONE RELEASING HORMONE-THERAPY AND GROWTH-HORMONE THERAPY IN GROWTH-HORMONE DEFICIENCY
    BUTENANDT, O
    STAUDT, B
    EUROPEAN JOURNAL OF PEDIATRICS, 1989, 148 (05) : 393 - 395
  • [37] THE 20,000-DA VARIANT OF HUMAN GROWTH-HORMONE DOES NOT BIND TO GROWTH-HORMONE RECEPTORS IN HUMAN LIVER
    MCCARTER, J
    SHAW, MA
    WINER, LA
    BAUMANN, G
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1990, 73 (01) : 11 - 14
  • [38] HUMAN GROWTH-HORMONE INDUCES DISULFIDE LINKAGE OF GROWTH-HORMONE RECEPTORS IN IM-9 CELLS
    FRANK, SJ
    GILLILAND, G
    CLINICAL RESEARCH, 1993, 41 (02): : A132 - A132
  • [39] HUMAN GROWTH-HORMONE AND HUMAN AGING
    CORPAS, E
    HARMAN, SM
    BLACKMAN, MR
    ENDOCRINE REVIEWS, 1993, 14 (01) : 20 - 39
  • [40] GROWTH-HORMONE RECEPTORS
    POSTELVINAY, MC
    ANNALES D ENDOCRINOLOGIE, 1989, 50 (05) : 404 - 408